FOG PHARMACEUTICALS INC has a total of 14 patent applications. Its first patent ever was published in 2018. It filed its patents most often in Australia, Canada and Singapore. Its main competitors in its focus markets pharmaceuticals and biotechnology are BEIJING MABWORKS BIOTECH CO LTD, SHATTUCK LABS INC and FORTY SEVEN INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | Australia | 2 | |
#2 | Canada | 2 | |
#3 | Singapore | 2 | |
#4 | WIPO (World Intellectual Property Organization) | 2 | |
#5 | Brazil | 1 | |
#6 | China | 1 | |
#7 | EPO (European Patent Office) | 1 | |
#8 | Israel | 1 | |
#9 | Republic of Korea | 1 | |
#10 | United States | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Peptides | |
#3 | Therapeutic chemical compounds |
# | Name | Total Patents |
---|---|---|
#1 | Mcgee John Hanney | 10 |
#2 | Verdine Gregory L | 10 |
#3 | Ortet Paula | 8 |
#4 | Hilinski Gerard | 8 |
#5 | Shim So Youn | 8 |
#6 | Patton Matthew Reiser | 6 |
#7 | Zhang Yue-Mei | 4 |
#8 | Thomson Ty Matthew | 4 |
#9 | Rezaei Araghi Raheleh | 4 |
#10 | Wahl Sebastian Christof Theodor | 4 |
Publication | Filing date | Title |
---|---|---|
AU2019326423A1 | Collections of peptides, peptide agents, and methods of use thereof | |
CN111372942A | β -catenin function modulating agents and methods thereof |